I’ve been diving into the recent updates on FDA submission guidelines, and it looks like there are significant changes coming that impact how we approach ethical considerations in clinical trials… For instance, the increased emphasis on informed consent procedures means we might need to adjust our protocols to ensure we’re meeting these new standards. Has anyone else started to adapt their documentation or processes in light of this?